The ICD-10-CM code for an unspecified leukopenia is D72.819, which means “Decreased white blood cell count, unspecified.” It is used when there is a documented case of leukopenia but no more precise indexation is present. Lymphopenia, neutropenia, and leukopenia due to medications may result in other codes being used.
When choosing a diagnosis code, the context of “low WBC” is as important as the result itself. This document outlines the distinctions between various codes, their documentation requirements, and clinical significance of low white blood cells.
ICD-10-CM codes for leukopenia at a glance
D72.819 is classified under the category D72.81, which includes leukopenias. D72.819 is a complete code while D72.81 is a subcategory heading that needs further subdivision and must not be used instead of the appropriate complete code.
“Unspecified” indicates the level of information provided for diagnostic purposes. “Unspecified” does not imply that all investigations must be done before coding can take place or that the code cannot be reported.
The table below is a selection tool that gives a description of the clinical differences between the terms. Consult the full index term and tabular list instructions in the CDC ICD-10-CM official guidelines.
| Documented condition or finding | Code | Selection point |
|---|---|---|
| Leukopenia without a more specific indexed diagnosis | D72.819 | General decreased WBC count without the detail needed for another code |
| Lymphopenia or lymphocytopenia | D72.810 | Reduced lymphocytes, a particular WBC population |
| Another specified reduction in WBCs | D72.818 | Includes indexed findings such as monocytopenia and eosinophilic leukopenia |
| Neutropenia without a more specific classification | D70.9 | Reduced neutrophils documented as the diagnosis |
| Leukopenia or neutropenia attributed to cancer chemotherapy | D70.1 | Follow the Index, neoplasm instruction, and applicable adverse-effect instruction |
| Other drug-induced leukopenia or neutropenia | D70.2 | Follow the indexed medication-related diagnosis and identify the drug when applicable |
| Neutropenia attributed to infection | D70.3 | Requires the documented diagnosis and relationship |
| Congenital forms indexed to this code | D70.0 | Use the exact documented condition rather than assuming all low counts are acquired |
| Cyclic neutropenia | D70.4 | Requires that specific diagnosis |
| Other specified neutropenia | D70.8 | Use when the Index directs the documented form here |
| Pancytopenia attributed to antineoplastic chemotherapy | D61.810 | Affects red cells, white cells, and platelets |
| Other drug-related pancytopenia | D61.811 | Requires documentation of pancytopenia and its drug relationship |
| Pancytopenia indexed to the “other” classification | D61.818 | Follow the diagnosis and relevant exclusions |
| Unspecified high WBC count, or leukocytosis | D72.829 | Represents the opposite direction of WBC abnormality |
The official classification supports these distinctions; the table does not replace its detailed instructions.
Codes such as D70.- and D61.81- indicate families, not complete claim entries. Select the complete code supported by the record.
Leukopenia in relation to white blood cell levels
Leukopenia refers to low white blood cell levels. White blood cells comprise neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Leukopenia could result from low levels in any one of these categories or a combination of some of them.
By itself, leukopenia does not provide information on the cause of low levels or whether there is an increased risk of infection, nor does it indicate any form of treatment.
Reference ranges and the limitations of using a numeric cutoff
The MedlinePlus website of the National Library of Medicine gives the common reference range of 4,500–11,000 WBC/µL, but adds that there could be variations among the laboratory reference ranges.
The count of 3,200/µL WBC would serve as sufficient evidence for the clinician to diagnose leukopenia, but not for the coder to decide between the use of D72.819, D72.810, or the D70 codes.
In addition, pay attention to units. The count reported as 3.2 × 10⁹/L WBC equals the count of 3,200/µL. Without reading the unit, confusion might occur in reviewing medical charts.
There is no numeric WBC cutoff in D72.819, which allows for automatic assignment of a diagnostic code. The laboratory makes an abnormal value identification, whereas the clinical documentation defines it.
ANC and lymphocyte counts address different concerns
Absolute Neutrophil Count (ANC) is a measure of the quantity of neutrophils, not WBC. According to the National Cancer Institute, ANC <500 cells per microliter indicates susceptibility to infections.
Absolute lymphocyte count reflects another group. A healthcare practitioner can diagnose lymphopenia based on the result of the test, patient’s characteristics, and additional information. NHLBI guidelines for diagnosing state that adult and pediatric lymphocyte ranges vary.
For coding, keep in mind the correlation between the population that was measured and the diagnosis made. A low WBC count does not necessarily mean lymphopenia. Lymphocyte percentage does not always indicate absolute lymphocyte count.
Selection Between D72.819, D72.810, and D72.818
All three codes have the same decreased-WBC feature, but they differ by the amount of detail provided. This is based on the documented diagnosis, rather than which code looks more detailed in a reference source.
D72.819 for unspecified leukopenia
Report D72.819 if the diagnosis in the documentation is leukopenia, leukocytopenia, or decreased WBC without any modifier that would lead to another code.
For example, “Leukopenia; cause undetermined; CBC with differential ordered” would justify reporting this code if the condition satisfies the reporting criteria for the encounter. The lack of a definitive cause does not mean you cannot report a condition that is already established.
“Unspecified” also does not mean “cause unknown.” There may be a related condition present but the documented WBC condition is unspecified. Refer to the Index for the specific diagnosis and relationship rather than applying the cause unknown principle.
D72.810 documented lymphopenia
D72.810 denotes lymphocytopenia or lymphopenia. It is better suited to use in the case of this specific decreased cell population than any other code for leukopenia, because it is classified as such.
Be careful to not get confused between lymphopenia and lymphocytosis – while the first denotes the absence of lymphocytes, the second denotes an abundance of them. Similar names can obscure very different meanings.
If the lab result is that of lymphopenia, but the assessment just states “abnormal CBC,” decide if more information is required. More details available on the lab result do not automatically constitute a diagnosis.
D72.818 another specified decrease
D72.818 is used in the case of other specified decreased WBC findings which are directed to this code by the Index. Examples of the conditions coded as such include monocytopenia, eosinophilic leukopenia, and basophilic leukopenia. ftp.cdc.gov
It may be said that the difference between “other” and “unspecified” is simply practical: “other” denotes a condition without a specific code in this class which has been diagnosed, and “unspecified” refers to insufficient information.
Just having a suspected cause does not make unspecified leukopenia an example of D72.818.
Neutropenia, leukopenia, and pancytopenia
Neutropenia is a decrease in neutrophils. Leukopenia refers to a decrease in the total WBC count. These conditions may be clinically interchangeable, but their coding methods differ.
D70 includes a variety of neutropenias and agranulocytosis. The unspecified choice is D70.9. Documentation of a cause or a subcategory directs the coder to another D70 code.
Let the diagnosis guide your interpretation of the differential
A coder interpreting low neutrophils should check the provider’s interpretation of the lab results. When the provider’s documentation is neutropenia, use the appropriate D70 code path. In the absence of any documentation or when the clinical significance of the finding is unclear, clarification should be obtained via the facility’s query procedure.
An exception exists to the vocabulary rule in the case of a modified leukopenia: the Index directs the coder to D70 even in the absence of the term neutropenia in the provider’s diagnosis. An example of such diagnosis is chemotherapy-induced leukopenia.
This is the reason why coding of only the diagnosis without its modifier may be incorrect.
Review Needed for Multiple Affected Cell Lines
Pancytopenia includes decreased red blood cells, white blood cells, and platelets. A pancytopenia diagnosis leads to D61.810, D61.811, D61.818, or other coding based on etiology and exclusions.
Pancytopenia should not be diagnosed just because there are three laboratory values that are low. Likewise, do not use three cytopenias instead of pancytopenia just because the record is coded.
The significance of the coding and treatment of the patient depends upon the proper diagnosis. Count pattern is an indicator to review the record; it does not mean making up a syndrome.
Excludes1, Excludes2 and Inherited coding instructions
Instructions may not necessarily come immediately after the code. Instructions could be found by just going through the description of the category or subcategory.
In the official Tabular List, the code for neutropenia is found in the Excludes2 category under codes D72 and D72.81. There is an Excludes1 instruction for leukemia in D72.8. There are also general instructions for the whole category D72 including immunity disorder and preleukemia.
Excludes1 generally prevents the reporting of the excluded condition
Generally, an Excludes1 note would indicate that there is no reporting of the excluded condition with the code. However, the official instruction acknowledges exceptions when the two conditions are not related. This will require further clarifications and not assumptions.
For instance, when a patient is diagnosed with leukemia, there will be a need to check the excluded code D72.8 and even go through the medical record. It would be inappropriate to add the code D72.819 just to report a blood condition associated with leukemia.
Exclude2 provides proper reporting for both conditions
An Excludes2 indicator indicates that the excluded condition is not part of the code. Both can be reported when the individual has both and the criteria for reporting are satisfied.
However, it does not mean that the coding should automatically be doubled up. The use of “leukopenia” and “neutropenia” as terms might refer to the same medical condition. Check whether there are any other separate reportable conditions, like lymphopenia and neutropenia, rather than simply adding the codes on seeing two different terminologies in the record.
Refer to the Tabular List relevant to the particular claim and the official guidelines issued by CMS. An exclusion note obtained from a completely different source cannot replace verification of the classification system.
Chemotherapy-induced and drug-induced leukopenia
Drug-induced causes illustrate the importance of the Alphabetic Index. Because of the established association, the code set could change, despite the presence of the general term “leukopenia” in the evaluation.
Index to the drug-induced diagnosis
The official Index states:
- Leukopenia induced by cancer chemotherapy D70.1
- Other drug-induced leukopenia NEC D70.2
- NEC stands for “not elsewhere classified.” It does not indicate “cause unspecified.” The term and the more detailed indexed disease need review.
D70.1 is coded along with the underlying neoplasm and an additional adverse effect code that identifies the drug in question. D70.2 also contains instructions about the use of an adverse effect code.
D72.819 and T45.1X5A should not be assigned to every instance of low WBC associated with chemotherapy. First, code the indexed blood disease, determine the causative drug and follow all coding instructions.
Differentiate an adverse effect and poisoning
An adverse effect resulting from the use of a properly prescribed and appropriately administered drug would be coded in the following manner: type of adverse effect, followed by the applicable drug adverse effect code, except when there are other coding guidelines for sequencing.
Poisoning entails factors like overdosing, wrong drug, or improper administration. It is different in sequencing. The occurrence of medication-related cytopenia does not mean that there was poisoning.
The code T45.1X5- might be used to code an adverse effect resulting from an applicable antineoplastic or immunosuppressive drug. Not all substances use this system; the classification of some is separate. Find out whether the specific drug belongs to the Table of Drugs and Chemicals. Confirm this from the Tabular List.
If you need to use a seventh character, choose it depending on the stage of care. For instance, the letter “A” indicates active treatment and not the first visit to a specific practice.
Fever and neutropenia need to be considered separately
The D70 category indicates that if there is also fever, then you should add the code R50.81. There might also be infection, mucositis or other complications requiring further investigation and coding.
Fever and low WBC levels do not necessarily indicate febrile neutropenia. Follow the physician’s diagnosis and guidelines. The NCI definition defines febrile neutropenia as fever with low neutrophil count, which is different from the low total WBC count.
Consult the accurate diagnosis in the authoritative reference
Crosscheck the coded term, its descriptors, and hereditary details in the CDC code browser prior to selecting the complete code.
Documentation that substantiates the code
The useful documentation is an explanation of the interpretation of the blood finding and the relationship between the finding and the services. There is no need for any pre-scripted language or listing of symptoms that do not exist in the patient.
Focused review of the medical record would search for:
- The diagnosis, for example, leukopenia, lymphopenia or neutropenia.
- An interpretation of the significance of the WBC, ANC or differential.
- The relationship if one has been made by the provider.
- The evaluation, treatment, monitoring or otherwise affected by the finding.
- Clarification where there are contradictions among the different parts of the record.
“Leukopenia, etiology undetermined; evaluate differential and refer to hematology,” documents the problem and what the plan will be. “Labs reviewed,” leaves much more to question.
Neutral inquiry
For example, CBC shows low WBC and reduced neutrophils, yet the diagnosis is stated only as “abnormal blood work.” Such an inquiry may be:
The records indicate low WBC and neutrophils levels. It is requested that the diagnosis, if present, be indicated along with its clinical meaning. Another valid option is to give either some other explanation or a finding without clinical importance, or state that the answer cannot be given due to lack of data.
Provide the necessary clinical markers and adhere to the query policy of the company. Do not ask for a diagnosis because it will raise the cost or be more precise.
Lab test results and interpretations of lab test reports are distinct entities
However, coders are not supposed to code a condition called leukopenia based on a single laboratory test result. On the other hand, it is also wrong to assume that a lab report will not be a good source for coding. For outpatient diagnostic services, what really matters is the interpretation of the lab report by the physician and the purpose for which the report was generated. This is particularly true for coding Laboratory Billing Services claims, in which the coder must know whether the physician identified and interpreted the abnormal lab result.
Outpatient versus inpatient reporting distinctions
In outpatient scenarios, probable, suspected, or rule-out conditions are usually not reported as an established diagnosis. Reporting the highest degree of certainty is recommended, where the finding is documented, as well as the reason for the visit.
For instance, “leukopenia; evaluate for marrow disorder” does not diagnose a marrow disorder. The diagnosed leukopenia might be coded without including the suspect condition as a disease.
On the other hand, there are different inpatient reporting rules, whereby some uncertain conditions documented on discharge can be reported according to inpatient rules, with additional diagnoses meeting the inpatient reporting requirements. Outpatient rules cannot simply be used in inpatient reporting without confirming their application.
Sequencing rules vary depending on the encounter type. There is no global rule regarding the sequencing of the underlying condition in all leukopenia cases. Other rules such as the reason for the encounter, drug-effect rule, and classifying instructions should be followed.
Screening, diagnostic tests, and preprocedural evaluation
While a preventive test and a service for evaluating documented leukopenia have a different purpose, the identification of the low WBC during screening does not mean that all services are for screening.
When selecting a preprocedural evaluation, look at the examination code, the indication for the procedure, and the reportable finding determined by the evaluation. It should be noted that leukopenia is not necessarily the primary diagnosis because it is included in the findings.
Moreover, distinguish the established condition from the problem list diagnosis. The title which is irrelevant to the encounter should not be used for the coding without review.
In particular, this distinction is helpful when the order, assessment, and claim indicate different things. Determine whether it reflects the preventive service, finding evaluation, complication treatment, or something else. The documentation must be clarified before the selection of the sequence.
Leukopenia illustration coding examples
These illustrations are fictional and provide only individual decision points. These are not complete claim coding guidelines or patient-specific medical advice.
Example 1: Cause unknown low total WBC
Documentation: “Leukopenia, WBC 3,200/µL. No cause found. CBC with differential ordered.”
Coding guideline: Code D72.819 is the right code for unspecified leukopenia if it fulfills the requirement of the encounter for coding. Investigation does not need to prove the cause of the condition for the documented diagnosis to qualify for coding.
Important documentation is the assessment. The number simply corroborates the assessment but does not substitute for it.
Example 2: Documented lymphopenia
The diagnosis assessment has lymphopenia as the WBC disorder under evaluation. There is a decreased absolute lymphocyte count.
Coding guideline: Do not default to D72.819; rather, check D72.810. Do not use both codes just for restating the condition by generic and specific terms.
There is an additional cytopenia established by the document. This must be evaluated separately.
Example 3: Unspecified neutropenia
The provider notes neutropenia, with an ordering of an evaluation, but there is no specific indexed form.
Coding direction: Code the unspecified neutropenia using D70.9. There is no need for an additional D72.819, even if there is a low total WBC in the CBC on the same encounter.
In case the diagnosis identifies the infection-related or the medication-related form, look up the corresponding indexed code instead of using the unspecified code.
Example 4: Leukopenia due to chemotherapy
The provider identifies the causative factor of leukopenia as cancer chemotherapy. The encounter deals with the adverse effect.
Coding direction: From the Index, use the code D70.1 for chemotherapy-related leukopenia. Follow the instructions regarding the underlying neoplasm and the causative drug.
It should be noted that mere identification of a person with cancer does not imply causation. Marrow involvement by the cancer process and the adverse effect are two different things.
Example 5: Leukopenia caused by another drug
This example demonstrates leukopenia that results from taking non-chemotherapy drug in the proper way. No more specific blood disorder indexed is identified.
Coding direction: Search for the drug-induced leukopenia pathway in the Index other than leading to D70.2 and determine the corresponding adverse effect code for the drug in question.
A chemotherapy drug code cannot be selected if the problem is with an unrelated medication and poisoning should not be assumed where an adverse effect of properly prescribed medication is mentioned.
Example 6: Abnormally low values of all three cell lines
Pancytopenia with decreased red cells, WBCs and platelets is diagnosed.
Coding direction: Look through the pancytopenia category and its cause-specific codes and exclusions. The code D61.818 might be assigned in accordance with the Index guidance for the documented condition. There are special codes for pancytopenia resulting from chemotherapy and other drugs.
The main task here is to capture the documented syndrome but not provide the diagnosis for every abnormal result.
Example 7: A low value without any assessment
There is a CBC flagged for low WBC; however, there is no provider interpretation or intervention for it in the encounter documentation available.
Coding instruction: Do not code leukopenia on your own. You should find out whether there is an interpretation available or whether there should be some clarifications according to the guidelines of the situation.
It is impossible to understand whether the provider finds the result significant from a clinical point of view, whether it is part of another disease or requires a diagnosis.
Causes and interpretation of leukopenia
WBC depletion can be associated with medications, cancer therapy, certain viral infections, autoimmune disorders, bone marrow diseases, and diseases of the spleen. Certain nutritional deficiencies and genetic diseases may be considered for individual patients.
They are all part of a differential diagnosis rather than being included on a list of diagnoses in the claim. Leukopenia does not indicate leukemia, HIV, lupus, or bone marrow failure. Each disease has its own criteria.
NHLBI’s overview of causes of lymphopenia mentions several factors, namely decreased cell production and cell death. The significance of the target population needs to be taken into account.
Testing should provide an answer to a clinical question
A CBC with differential will reveal which subpopulations of the WBCs are decreased. Blood smear, medication history, nutrition work-up, infectious work-up, or referral to a specialist are possible approaches based on the findings.
Flow cytometry, serology, or bone marrow work-up are used for certain diagnostic purposes. Not all cases with low WBCs need them. NHLBI guidelines describe the role of some of these tests for lymphopenia diagnosis.
For coders, the order of a bone marrow biopsy does not mean the presence of the bone marrow problem. An HIV test order does not mean that a patient has HIV. The purpose of testing and the provider’s opinion about it are two separate things.
Management and signs to watch for
It varies by the underlying cause and the type of cells involved. The provider can opt for observation, treatment of any infection or deficiency, modification of the offending drug, or management of the underlying blood disorder or immunological condition. There is no particular management procedure associated with D72.819.
Similar considerations apply to the NHLBI recommendations about treatment. People should not discontinue any prescribed medications or take any supplements to increase the WBC count without prior discussion with their healthcare provider.
The low count may not cause any symptoms. The signs of infection, but not the count itself, may lead to identification of the condition. Some of the issues include fever, chills, mouth sores, cough, or pain while urinating.
Fever along with known neutropenia is a medical emergency. For people under chemotherapy, the CDC recommends that fever of 100.4°F/38°C or above is an indicator for contacting their treatment team and following their guidelines for emergency care.
The severity of symptoms requires clinical assessment. The diagnosis code does not fully convey the seriousness of the situation.
Billing errors that a focused review would detect
Another common coding mistake involves the confusion of D72.819 that stands for the decreased WBC with D72.829 that stands for the elevated WBC count. It is necessary to confirm the clinical sense along with the numbers. Among other mistakes, there are the choice of the parent category, the missed modifier in the Alphabetic Index, the duplicate use of a particular code and the mistaken assumption that the test order represents the confirmed diagnosis.
Unspecified code is not necessarily wrong. It can reflect the documented information. Additional specificity is meaningless. It is necessary to distinguish an unspecified code from a complete diagnosis code in Medical Billing Services, since the coding accuracy should be considered apart from the coverage. It is not enough to have a complete diagnosis code in order to get paid for a CBC, flow cytometry or bone marrow procedure. The order, the clinical documentation, and the payer policy must also support the billing. The coverage and billing guidelines issued by CMS for particular procedures prove this.
Finally, fever, infection or blood disease should never be added to the diagnosis code for the purpose of reimbursement.
Pre-submission test of practicality
Apply a short series, ensuring the linkage between the record and coding:
- Read the assessment. Find out what the condition is actually documented as by the provider.
- Get modifiers. Document the population of the cell, cause, and any medication relation.
- Look up the Index. Do not go by “leukopenia” but follow the whole term.
- Check the Tabular List. Look at the parents, exclusions, and additional code instructions.
- Follow the guidelines of the setting. Find out the reportability and the reason for the encounter.
- Clarify the unclear issues. Clarify the conflicting or incomplete information by asking a query.
- Check the claim. Verify the whole code, the coding sequence, and requirements for the service covered.
Such approach is also good for learning. Give the task to a student: explain the term, its indexing path, and its role in the claim. The right explanation will be based on all three aspects, not on the memorized code.
Frequently asked questions
Which ICD-10 code is used for unspecified leukopenia?
D72.819 represents decreased white blood cell count, unspecified, including unspecified leukopenia. A more specific documented condition can change the selection. Lymphopenia belongs to D72.810, while neutropenia and certain medication-related leukopenia diagnoses lead to the D70 category. Confirm the complete diagnostic phrase in the Index.
Is D72.819 a billable diagnosis code?
Yes. D72.819 is a complete ICD-10-CM diagnosis code, unlike its parent D72.81. It may support a claim when the documentation and reporting rules justify it. Billable status does not guarantee coverage or payment for a particular service; medical necessity and applicable payer requirements still apply.
Are leukopenia and neutropenia coded the same way?
They describe different findings. Leukopenia concerns the total WBC count; neutropenia concerns neutrophils. Unspecified leukopenia generally maps to D72.819, while unspecified neutropenia maps to D70.9. The Index also directs some modified leukopenia diagnoses to D70 codes, including chemotherapy-induced and other drug-induced forms, so review the full wording.
Can a coder assign leukopenia from a CBC result alone?
A coder should not independently diagnose leukopenia from a numerical CBC result. Review the provider’s assessment and the rules for the setting. For outpatient diagnostic services, a confirmed diagnosis in an appropriate physician-interpreted report may be reportable. That differs from deriving a diagnosis from raw laboratory values.
Which code applies to chemotherapy-induced leukopenia?
The Alphabetic Index directs cancer chemotherapy-induced leukopenia to D70.1. Review the Tabular List instructions for the underlying neoplasm and any applicable drug adverse-effect code. Identify the actual agent and required encounter character. D72.819 plus a generic chemotherapy code is not a universal substitute for this indexed pathway.
Can leukopenia and neutropenia be reported together?
The D72 and D72.81 categories list neutropenia under Excludes2, so reporting both is not categorically prohibited. Both must represent appropriately documented, reportable conditions. Do not duplicate the same clinical problem with a general and specific label. Review separate conditions, inherited notes, and any unclear relationship before assigning both.
Apply the documentation checklist
Utilize the process of review of the claim-checklist to verify the diagnosis, index modifiers, and reporting criteria in the challenging case of low WBC.
Selecting the code supported by the record
D72.819 resolves the coding dilemma of the basic leukopenia, however, the phrasing of the diagnosis will dictate if this is the right choice. Find out the involved cells, consult the modifier indexes and take a look at the inheritance codes. Better to have documentation and a correct code than any assumptions based on one lab test.
